http://www.fpnotebook.com/
Neutropenic FeverAka: Febrile Neutropenia
- Diagnosis
- Fever: Temperature at least 101 F (38.3 C) and
- Neutropenia: Absolute Neutrophil Count <500/mm3
- Labs
- Complete Blood Count with differential
- Determine Absolute Neutrophil Count (ANC)
- Blood Cultures
- Site-specific cultures as indicated
- Liver transaminases
- Renal Function tests
- Complete Blood Count with differential
- Evaluation
- See Neutropenic Fever Clinical Decision Rule
- Use Clinical Decision Rule to define high or low risk
- High risk criteria
- Inpatient
- Serum Creatinine >2 mg/dl
- Liver Function Tests >3 fold increased above normal
- Pneumonia
- Uncontrolled or progressive cancer
- Serious comorbidity
- Absolute Neutrophil Count <100/mm
- Absolute Neutrophil Count <500/mm
- Low risk criteria
- Outpatient
- No comorbidity
- Neutropenia of short duration
- Serum Creatinine <2 mg/dl
- Liver Function Tests <3 fold increased above normal
- Active and independent functional status
- References
- Management: General
- Evaluation (see above) determines level of risk
- Indication for Vancomycin protocol as listed below
- Consider Antifungals if no improvement in 3 days
- Other medications not routinely used
- Antiviral medications
- Granulocyte transfusions
- Colony stimulating factors
- Management: Low risk
- Duration of antibiotics: Based on re-evaluation day 3-5
- Option 1: Oral antibiotics
- Ciprofloxacin PO and
- Augmentin PO
- Option 2: Intravenous antibiotics
- See High Risk cases below
- Management: High risk with Vancomycin Needed
- Indications for Vancomycin
- Inpatient setting where MRSA is common
- Serious catheter related infection
- Patient known to be colonized
- Methicillin Resistant Staphlyococcus aureus (MRSA)
- Penicillin Resistant Pneumococcus (PRP)
- Cephalosporin-resistant pneumococci
- Initial Blood Cultures positive for Gram Positives
- Cardiovascular compromise
- Protocol
- Vancomycin and
- Cephalosporin
- Cefepime or
- Ceftazidime or
- Carbapenem
- Consider adding Aminoglycoside
- Indications for Vancomycin
- Management: High risk without Vancomycin Needed
- Option 1: Intravenous monotherapy antibiotics
- Cefepime or
- Ceftazidime or
- Carbapenem
- Option 2: Intravenous 2 drug therapy
- Aminoglycoside and
- Penicillin or Cephalosporin
- Extended Spectrum Penicillin for Pseudomonas or
- Cefepime or
- Ceftazidime
- Carbapenem
- Option 1: Intravenous monotherapy antibiotics
- References
Febrile neutropenia (C0746883) | |
|---|---|
| Concepts | Disease or Syndrome (T047) |
| English | Febrile neutropenia, Neutropenic Fever |
| Spanish | neutropenia febril |
| Parent Concepts | Fever (C0015967), Neutropenia (C0027947), Febrile leukopenia (C1960456) |
| Sources | NCI, SCTSPA, SNOMEDCT Derived from the NIH UMLS (Unified Medical Language System) |